Market Cap 3.12B
Revenue (ttm) 3.79B
Net Income (ttm) -910.00M
EPS (ttm) N/A
PE Ratio 9.21
Forward PE 8.17
Profit Margin -23.99%
Debt to Equity Ratio 0.79
Volume 2,773,400
Avg Vol 2,778,406
Day's Range N/A - N/A
Shares Out 199.29M
Stochastic %K 88%
Beta 0.95
Analysts Sell
Price Target $18.19

Company Profile

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 844 848 0137
Address:
13320 Ballantyne Corporate Place, Charlotte, United States
11thestate
11thestate Jun. 26 at 10:21 AM
$XRAY investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #DentsplySirona $XRAY https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
11thestate
11thestate Jun. 16 at 11:36 AM
Don’t forget that there is also an important class action case to watch for $XRAY. We have every detail, including how investors can get paid. #DentsplySirona #XRAY https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 5:34 PM
$XRAY's digital revolution in dentistry is catching eyes, but is it enough to counter demand softness in Europe? 🤔 🔹 New Azento solution enhancing implant workflows in key markets 🔹 R&D spending ramping up to fuel innovation 🔹 Q1 adjusted operating profit surged by 46.9% from the prior-year quarter Yet, European demand dips pose a challenge. Full analysis here 👉 https://www.zacks.com/commentary/2494478/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2494478-body&ADID=SYND_STOCKTWITS_TWEET_2_2494478_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 4:13 PM
$XRAY gaining traction — but is it strong enough to buy now? The stock’s momentum is driven by a robust product portfolio, even as macro headwinds like weakened global demand linger. Fundamental insights here 👉 https://www.zacks.com/stock/news/2494478/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2494478-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494478_TEASER
0 · Reply
Nelsin
Nelsin Jun. 6 at 2:19 PM
$XRAY I'd like to start shorting this around $25 with the expectation of scaling the position at $35. Longs, get on it! The option chain is boring other than that open interest at $15 for June calls.
0 · Reply
MrNotSoNice
MrNotSoNice Jun. 6 at 1:24 PM
$XRAY Seems like I’m paying thousands to my dentist. 🙄📈💰
0 · Reply
11thestate
11thestate Jun. 5 at 11:07 PM
Don’t forget that if you held $XRAY, there’s a significant settlement you can also claim. Consider it the dividend #DentsplySirona never paid. https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
Broview
Broview Jun. 4 at 10:12 AM
$XRAY dust settled?
0 · Reply
DeepTactixFund
DeepTactixFund May. 28 at 4:44 PM
$XRAY ⁨🚨 JFB Just Set a New 52-Week High - and It Might Be Just the Start 🚨 JFB Construction Holdings (JFB) is on an absolute tear today - now trading at $6.18, up +17.6% intraday, and hitting a fresh 52-week high. 📈 Why the momentum? Here’s what’s fueling the breakout: ✅ $69.5M+ in contracts signed for 2025 - just announced ✅ 93% YoY revenue growth in Q1 2025 ✅ No dilution, no insider selling, tight float ✅ Active construction projects in 36 U.S. states ✅ 100% of business comes from referrals + repeat clients Volume has already blown past the daily average within the first hour - this isn’t hype, it’s real institutional-level interest showing up. This is a micro-cap with a mega-growth profile. If this trajectory continues, double digits aren’t out of the question short term. The float is thin, the tape is hot, and momentum is building FAST. If you’re not watching JFB yet - now’s the time. The stealth phase is over⁩
0 · Reply
11thestate
11thestate May. 28 at 10:27 AM
$XRAY investors, if you follow us, you already knew about it. This is the good news you needed about $XRAY today. Go check it out. #DentsplySirona #XRAY https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
Latest News on XRAY
Buying Dentsply Sirona

Jun 4, 2025, 6:34 PM EDT - 21 days ago

Buying Dentsply Sirona


Dentsply Sirona Declares Quarterly Cash Dividend

May 27, 2025, 4:15 PM EDT - 4 weeks ago

Dentsply Sirona Declares Quarterly Cash Dividend


DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:04 AM EDT - 6 weeks ago

DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript


Dentsply Sirona Reports First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 7 weeks ago

Dentsply Sirona Reports First Quarter 2025 Results


DENTSPLY SIRONA Inc. (XRAY) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:01 PM EST - 4 months ago

DENTSPLY SIRONA Inc. (XRAY) Q4 2024 Earnings Call Transcript


11thestate
11thestate Jun. 26 at 10:21 AM
$XRAY investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #DentsplySirona $XRAY https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
11thestate
11thestate Jun. 16 at 11:36 AM
Don’t forget that there is also an important class action case to watch for $XRAY. We have every detail, including how investors can get paid. #DentsplySirona #XRAY https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 5:34 PM
$XRAY's digital revolution in dentistry is catching eyes, but is it enough to counter demand softness in Europe? 🤔 🔹 New Azento solution enhancing implant workflows in key markets 🔹 R&D spending ramping up to fuel innovation 🔹 Q1 adjusted operating profit surged by 46.9% from the prior-year quarter Yet, European demand dips pose a challenge. Full analysis here 👉 https://www.zacks.com/commentary/2494478/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2494478-body&ADID=SYND_STOCKTWITS_TWEET_2_2494478_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 11 at 4:13 PM
$XRAY gaining traction — but is it strong enough to buy now? The stock’s momentum is driven by a robust product portfolio, even as macro headwinds like weakened global demand linger. Fundamental insights here 👉 https://www.zacks.com/stock/news/2494478/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2494478-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494478_TEASER
0 · Reply
Nelsin
Nelsin Jun. 6 at 2:19 PM
$XRAY I'd like to start shorting this around $25 with the expectation of scaling the position at $35. Longs, get on it! The option chain is boring other than that open interest at $15 for June calls.
0 · Reply
MrNotSoNice
MrNotSoNice Jun. 6 at 1:24 PM
$XRAY Seems like I’m paying thousands to my dentist. 🙄📈💰
0 · Reply
11thestate
11thestate Jun. 5 at 11:07 PM
Don’t forget that if you held $XRAY, there’s a significant settlement you can also claim. Consider it the dividend #DentsplySirona never paid. https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
Broview
Broview Jun. 4 at 10:12 AM
$XRAY dust settled?
0 · Reply
DeepTactixFund
DeepTactixFund May. 28 at 4:44 PM
$XRAY ⁨🚨 JFB Just Set a New 52-Week High - and It Might Be Just the Start 🚨 JFB Construction Holdings (JFB) is on an absolute tear today - now trading at $6.18, up +17.6% intraday, and hitting a fresh 52-week high. 📈 Why the momentum? Here’s what’s fueling the breakout: ✅ $69.5M+ in contracts signed for 2025 - just announced ✅ 93% YoY revenue growth in Q1 2025 ✅ No dilution, no insider selling, tight float ✅ Active construction projects in 36 U.S. states ✅ 100% of business comes from referrals + repeat clients Volume has already blown past the daily average within the first hour - this isn’t hype, it’s real institutional-level interest showing up. This is a micro-cap with a mega-growth profile. If this trajectory continues, double digits aren’t out of the question short term. The float is thin, the tape is hot, and momentum is building FAST. If you’re not watching JFB yet - now’s the time. The stealth phase is over⁩
0 · Reply
11thestate
11thestate May. 28 at 10:27 AM
$XRAY investors, if you follow us, you already knew about it. This is the good news you needed about $XRAY today. Go check it out. #DentsplySirona #XRAY https://11th.com/cases/dentsplysirona-investor-settlement
0 · Reply
11thestate
11thestate May. 27 at 11:09 AM
$XRAY investors, if you follow us, you already knew about it. This is one of those things you really don’t want to miss. Go check it out. #DENTSPLYSIRONA #XRAY
0 · Reply
ils85
ils85 May. 22 at 2:10 PM
$XRAY loading
0 · Reply
MDrive
MDrive May. 16 at 5:51 PM
$XRAY dumbo republicans banning fluoride. Kids will get lots of cavities sadly but this company should benefit. $SPY $TSLA $APPL $NVDA
5 · Reply
MrNotSoNice
MrNotSoNice May. 16 at 6:56 AM
$XRAY All those new children’s cavities in Florida should be good for business. 🦷🥴📈💰 https://abcnews.go.com/Health/florida-2nd-state-ban-fluoride-public-drinking-water/story?id=121852274
1 · Reply
MrNotSoNice
MrNotSoNice May. 16 at 6:34 AM
$XRAY All those new children’s cavities in Florida should be good for business. 🦷🥴📈💰 https://abcnews-go-com.cdn.ampproject.org/v/s/abcnews.go.com/amp/Health/florida-2nd-state-ban-fluoride-public-drinking-water/story
0 · Reply
11thestate
11thestate May. 14 at 10:46 AM
$XRAY investors filed a lawsuit against Dentsply Sirona for misleading them about the safety and compliance of its Byte aligner business. You can check if you are eligible and file for the payment here: https://11th.com/cases/dentsply-investor-suit
0 · Reply
PenkeTrading
PenkeTrading May. 13 at 4:50 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Dentsply Sirona Inc. Is that bullish or bearish? $XRAY #RsiOverbought #NASDAQ
0 · Reply
Winning_calls
Winning_calls May. 12 at 1:33 PM
$XRAY 🤞🤞
0 · Reply
JarvisFlow
JarvisFlow May. 12 at 12:00 PM
Barrington Research has adjusted their stance on Dentsply Sirona ( $XRAY ), setting the rating to Outperform with a target price of 20 → 21.
0 · Reply
Winning_calls
Winning_calls May. 12 at 2:20 AM
$XRAY pick me up @ $16.30
0 · Reply
JarvisFlow
JarvisFlow May. 9 at 10:30 PM
UBS has updated their rating for Dentsply Sirona ( $XRAY ) to Buy with a price target of 25.
0 · Reply
MrNotSoNice
MrNotSoNice May. 8 at 2:15 PM
$XRAY Nobody loves this stock but that was a good quarter. RFK cutting fluoride should help a lot. Let’s profit from MAGA wrecking children’s teeth. 🧐💰📈
0 · Reply